Health Canada has approved Victoza(R) (liraglutide), said to be the first GLP-1 analogue, for once-daily treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea....
http://finance.yahoo.com/news/Unique-treatment-for-type-2-cnw-3278831258.html?x=0&.v=1
http://finance.yahoo.com/news/Unique-treatment-for-type-2-cnw-3278831258.html?x=0&.v=1